Cassava Sciences (NASDAQ:SAVA – Get Free Report) had its price objective hoisted by investment analysts at HC Wainwright from $124.00 to $131.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Cassava Sciences Stock Performance Shares of NASDAQ:SAVA opened at $21.56 on Friday. The firm […]

Related Keywords

, Hedge Funds Weigh In On Cassava Sciences , Headlands Technologies , Montaga Associates Inc , Nasdaq , Cassava Sciences , Cassava Sciences Stock Performance , Cassava Sciences Inc , Cassava Sciences Company Profile , Benjaminf Edwards Company Inc , Entrypoint Capital , News Ratings For Cassava Sciences Daily , Get Free Report , Financial Advisors , Point Capital , Cassava Sciences Daily ,